Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sirona Biochem Corp
V.SBM
Alternate Symbol(s):
SRBCF
Healthcare
Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to...
large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:SBM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
...
Next
(80)
•••
bealert
X
View Profile
View Bullboard History
Comment by
bealert
on Jan 18, 2024 3:00am
RE:Bealert - you have to be joking!
I know you want this to succeed as much as anyone. If you feel offended by my earlier comments, I apologize for the sake of keeping peace in the family of investors. Nevertheless, this entity was
...more
(101)
•••
biorun
X
View Profile
View Bullboard History
Post by
biorun
on Jan 17, 2024 4:35pm
Bealert - you have to be joking!
Serious - we are all jaded and will not trust them until they produce revenue. That is the truth. While others may jump on board if they see something we don't, we have been chicken littled to
...more
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 24, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(2104)
•••
tylerreddick
X
View Profile
View Bullboard History
Comment by
tylerreddick
on Jan 17, 2024 3:41pm
RE:BIORUNS - You have to be joking, no?
Anyone who thinks $5 million/year in revenue would push the share price to 40 cents just shows they are not a serious investor.
(80)
•••
bealert
X
View Profile
View Bullboard History
Post by
bealert
on Jan 17, 2024 2:49pm
BIORUNS - You have to be joking, no?
You posted this stupid statement and think you are clever: Well, if the existing shareholders weren't so jaded and distrusting of management then we would likely be trading at 30-40 cents, easy
...more
(101)
•••
biorun
X
View Profile
View Bullboard History
Comment by
biorun
on Jan 17, 2024 12:54pm
RE:RE:RE:RE:No update yet - why?!
Well, if the existing shareholders weren't so jaded and distrusting of management then we would likely be trading at 30-40 cents, easy peasy. They did that not us. Sorry, but we have to be
...more
(2104)
•••
tylerreddick
X
View Profile
View Bullboard History
Comment by
tylerreddick
on Jan 17, 2024 12:38pm
RE:RE:RE:No update yet - why?!
" $4-5 million a year over the next 15 years would translate into $60-75M in revenue " If those numbers impress you, that would explain a lot.
(101)
•••
biorun
X
View Profile
View Bullboard History
Comment by
biorun
on Jan 17, 2024 11:59am
RE:RE:No update yet - why?!
Interesting perspective. There is a need to distinguish who bought the licencing and global nature and structure of the agreement. Some critical details are not available to us like the royalty rate
...more
(2104)
•••
tylerreddick
X
View Profile
View Bullboard History
Comment by
tylerreddick
on Jan 16, 2024 10:52pm
RE:RE:No update yet - why?!
1067 wouldn't be a "marginal" product if howie had the balls to sell it into the multi-billion dollar skin-lightening market. Trying to be politically correct has cost the company
...more
(2138)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Jan 16, 2024 8:52pm
RE:No update yet - why?!
Don't believe co. BS that Abbvie deal will make co. profitable. Assume 1067 is a marginal product. Hope that 1326 is the big winner.
(2104)
•••
tylerreddick
X
View Profile
View Bullboard History
Comment by
tylerreddick
on Jan 16, 2024 7:03pm
RE:RE:No update yet - why?!
If AbbVie doesn't do anything this year, it may be time to give up on this one.
(77)
•••
Pareto8020
X
View Profile
View Bullboard History
Comment by
Pareto8020
on Jan 16, 2024 6:02pm
RE:No update yet - why?!
AbbVie assisted in the clinical trial and bought exclusive worldwide rights so I'm confident a company as sophisticated as Allergan will be moving forward with incorporating the SBM compound into
...more
(75)
•••
forhandlaren
X
View Profile
View Bullboard History
Post by
forhandlaren
on Jan 16, 2024 5:25pm
No update yet - why?!
I find it interesting that the web site still notify a future investor presentation update. So will there be additional news in the near future? I would suggest AbbVie product launch. After all, it
...more
(2104)
•••
tylerreddick
X
View Profile
View Bullboard History
Post by
tylerreddick
on Jan 16, 2024 4:25pm
Some of us may die before Howie ever delivers,
But others might just live long enough for this decades-long pain to be relieved. If they ever get their act together, there might just be some money to be made. I have a feeling that the lowly
...more
(10)
•••
PeterG
X
View Profile
View Bullboard History
Comment by
PeterG
on Jan 16, 2024 3:47pm
RE:RE:RE:RE:What's this?
Howard is the largest shareholder from Sirona followed by Geraldine. Why should they only offer special gains to new investors like private equity firms? Sirona laboratories is a 100% subsidiary from
...more
Prev
...
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >